Overview

Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer

Status:
Terminated
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the change in quality of life over a 6 month period between gabapentin and venlafaxine in men with prostate cancer treated for hot flashes related to androgen deprivation therapy.
Phase:
Phase 2
Details
Lead Sponsor:
University of Wisconsin, Madison
Treatments:
Gabapentin
gamma-Aminobutyric Acid
Venlafaxine Hydrochloride